Join the Heart Failure group to help and get support from people like you.
Heart Failure News (Page 4)
Related terms: CHF
Ozempic, Wegovy Have Health Benefits Beyond Weight Loss, Studies Find
FRIDAY, Aug.30, 2024 – New trials are showing how the blockbuster diabetes and weight-loss meds Ozempic and Wegovy can boost health in even more ways. These two injected drugs are versions of...
Semaglutide Reduces Risk for MACE in Patients With Obesity and Heart Failure
WEDNESDAY, Aug. 28, 2024 – Semaglutide reduces the risk for major adverse cardiovascular events (MACE) and composite heart failure end points compared with placebo in patients with overweight or...
Wegovy Helps Patients With Heart Failure Avoid Heart Attack, Stroke
FRIDAY, Aug. 23, 2024 – Research has already proven that the blockbuster weight-loss drug Wegovy (semaglutide) can slash a person's odds for heart attacks and strokes, and now more data from the...
Study Reveals Heart Failure Risks in American Indian Communities
THURSDAY, Aug. 22, 2024 – A study published online Aug. 21 in the Journal of the American Heart Association reveals the major contributors to heart failure risk in American Indians, highlighting the...
Mitral Valve Surgery Linked to Lower Rates of Adverse Outcomes in AFMR
THURSDAY, Aug. 22, 2024 – For patients with atrial functional mitral regurgitation (AFMR), mitral valve (MV) surgery is associated with lower rates of adverse clinical outcomes, according to a study...
CMR-Modeled PCWP Independent Risk Factor for Heart Failure
THURSDAY, Aug. 22, 2024 – Elevated cardiovascular magnetic resonance (CMR) imaging-modeled pulmonary capillary wedge pressure (PCWP) is an independent risk factor for heart failure and major adverse...
scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the Furoscix Indication in Heart Failure
Furoscix is now indicated for the treatment of congestion due to fluid overload in adult patients with chronic heart failure, regardless of New York Heart Association (NYHA) functional class...
Follow-Up Has Improved for AMI, Heart Failure Hospitalization
MONDAY, Aug. 5, 2024 – Follow-up has improved for patients with acute myocardial infarction (AMI) and heart failure, but disparities persist in follow-up rates, according to a study published online...
Digoxin, Beta-Blockers Have Equivalent Effects on Heart Rate in A-Fib
TUESDAY, July 23, 2024 – For patients with atrial fibrillation, digoxin and beta-blockers have equivalent effects on heart rate at rest and on exertion, according to a study published online July 15...
Large Geographic Variation Seen With Heart Failure Phenotypes
THURSDAY, July 18, 2024 – There is substantial geographic variation in patient characteristics, treatment, and outcomes among patients with heart failure with preserved ejection fraction (HFpEF) or...
Second Recipient of Genetically Modified Pig Kidney Has Died
WEDNESDAY, July 10, 2024 – The second person to receive a kidney from a genetically modified pig has died, surgeons at NYU Langone Health announced Tuesday. The 54-year-old patient, Lisa Pisano, had...
ADA: Semaglutide Similarly Effective in Men, Women With Obesity-Linked Heart Failure
WEDNESDAY, June 26, 2024 – For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight to a greater extent in women but yields similar...
Wegovy Helps Heart Failure Patients Lose Weight, Improve Symptoms
TUESDAY, June 24, 2024 – Weight-loss drugs like Wegovy can improve symptoms in heart failure patients, a new clinical trial shows. Both men and women showed improved heart function after a year on...
Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
BASKING RIDGE, N.J. & SHIRLEY, N.Y.--(BUSINESS WIRE) June 05, 2023 --Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug...
FDA Approves Inpefa (sotagliflozin) for the Treatment of Heart Failure
THE WOODLANDS, Texas, May 26, 2023 (GLOBE NEWSWIRE) – Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the U.S. Food and Drug Administration (FDA) has approved Inpefa™ (...
Further information
Related condition support groups
Left Ventricular Dysfunction, Cardiovascular Conditions and Disorders
Related drug support groups
lisinopril, metoprolol, warfarin, spironolactone, Coumadin, triamcinolone, carvedilol, Metoprolol Succinate ER, diltiazem, view more... Lasix, furosemide, Entresto, bisoprolol, valsartan, Farxiga, Jardiance, ramipril, digoxin, prazosin, Diovan, nitroglycerin, Coreg